Cerner Declares Quarterly Dividend
September 11 2019 - 9:01AM
Cerner (NASDAQ: CERN) announced its Board of Directors has declared
a cash dividend to stockholders of $0.18 per issued and outstanding
share. The cash dividend will be payable on Oct. 9, 2019, to
shareholders of record as of the close of business on Sept. 25,
2019.
Cerner intends to pay regular quarterly cash
dividends, with future declarations subject to approval by its
Board of Directors and their determination that the declaration of
dividends remains in the best interests of Cerner and its
shareholders. The decision of whether to pay future dividends and
the amount of any such dividends will be based on the Company’s
financial position, results of operations, cash flows, capital
requirements, the requirements of applicable law and any other
factors the Board of Directors may deem relevant.
About Cerner
Cerner’s health technologies connect people and
information systems at more than 27,500 contracted provider
facilities worldwide dedicated to creating smarter and better care
for individuals and communities. Recognized globally for
innovation, Cerner assists clinicians in making care decisions and
assists organizations in managing the health of their populations.
The company also offers an integrated clinical and financial system
to help manage day-to-day revenue functions, as well as a wide
range of services to support clinical, financial and operational
needs, focused on people. For more information,
visit Cerner.com, The Cerner Blog or connect
on Facebook, Instagram, LinkedIn, Twitter or The
Cerner Podcast. Nasdaq: CERN. Smarter Care. Better
Outcomes. Healthier You.
All statements in this press release that do not
directly and exclusively relate to historical facts constitute
forward-looking statements. These forward-looking statements are
based on the current beliefs, expectations and assumptions of
Cerner's management with respect to future events and are subject
to a number of significant risks and uncertainties. It is important
to note that Cerner's performance, and actual results, financial
condition or business could differ materially from those expressed
in such forward- looking statements. The words “intends,” “future”,
“estimate”, “anticipate”, or the negative of these words,
variations thereof or similar expressions are intended to identify
such forward-looking statements. For example, our forward-looking
statements include statements regarding future dividends. Factors
that could cause or contribute to such differences include, but are
not limited to: possibility of significant costs and reputational
harm related to product related liabilities; potential claims for
system errors and warranties; the possibility of interruption at
our data centers or client support facilities, or those of third
parties with whom we have contracted (such as public cloud
providers), that could expose us to significant costs and
reputational harm; the possibility of increased expenses, exposure
to legal claims and regulatory actions and reputational harm
associated with a cyberattack or other breach in our IT security or
the IT security of third parties on which we rely; our proprietary
technology may be subject to claims for infringement or
misappropriation of intellectual property rights of others, or may
be infringed or misappropriated by others; material adverse
resolution of legal proceedings or other claims; risks associated
with our global operations, including without limitation greater
difficulty in collecting accounts receivable and stringent data
privacy regulations; risks associated with fluctuations in foreign
currency exchange rates; changes in tax laws, regulations or
guidance that could adversely affect our tax position and/or
challenges to our tax positions in the U.S. and non-U.S. countries;
risks related to our dependence on strategic relationships and
third-party suppliers; risks inherent with business acquisitions
and combinations and the integration thereof into our business or
relating to disputes involving such acquisitions or combinations;
risks associated with volatility and disruption resulting from
global economic or market conditions; significant competition and
our ability to quickly respond to market changes, changing
technologies and evolving pricing and deployment methods and to
bring competitive new solutions, devices, features and services to
market in a timely fashion; managing growth in the new markets in
which we offer solutions, health care devices or services; long
sales cycles for our solutions and services; risks associated with
our outstanding and future indebtedness, such as compliance with
restrictive covenants, which may limit our flexibility to operate
our business; changes in accounting standards issued by the
Financial Accounting Standards Board or other standard-setting
bodies may adversely affect our financial statements; the potential
for losses resulting from asset impairment charges; changing
political, economic, regulatory and judicial influences, which
could impact the purchasing practices and operations of our clients
and increase costs to deliver compliant solutions and services;
non-compliance with laws, government regulation or certain industry
initiatives or failure to deliver solutions or services that enable
our clients to comply with laws or regulations applicable to their
businesses; variations in our quarterly operating results;
potential variations in our sales forecasts compared to actual
sales; volatility in the trading price of our common stock and the
timing and volume of market activity; inability to reduce expenses
and costs to the extent currently anticipated; risks that Cerner’s
revenue growth may be lower than anticipated and/or that the mix of
revenue shifts to low margin revenue; risks that our stock
repurchase program or quarterly dividend program will not be fully
implemented or enhance long-term shareholder value; risks that
Cerner’s business may be negatively affected as a result of future
proxy fights or the actions of activist shareholders;. Additional
discussion of these and other risks, uncertainties and factors
affecting Cerner’s business is contained in Cerner’s filings with
the Securities and Exchange Commission. The reader should not place
undue reliance on forward-looking statements, since the statements
speak only as of the date that they are made. Except as required by
law, Cerner undertakes no obligation to update or revise
forward-looking statements to reflect changed assumptions, the
occurrence of unanticipated events, or changes in our business,
results of operations or financial condition over time.
Investor Contact: Allan Kells,
(816) 201-2445, akells@cerner.com Media Contact:
Misti Preston, (816) 299-2037, misti.preston@cerner.com
Cerner's Internet Home Page: www.cerner.com
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Apr 2024 to May 2024
Cerner (NASDAQ:CERN)
Historical Stock Chart
From May 2023 to May 2024